Feds buy another $1.29B worth of Lilly antibody treatment for COVID-19

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

fip i atnpmnceCaptis-e .IyiIed n l-,ueicddadnucD ns e h titemyCS owt.k.ghn enus at1ea.sy.viaa tnnfoerm$ohh1 b Ul lisp poutengaemTrLyd lma nnsatgio,a rE d9lag opruoebaipnoillayotdrora2 omrfa g9uOiib lin nohertnaa yln mbrccT oend’Vdstia

auca0hrv td h T4latp,me ng somhpiat sc m n,0 ul oeLs bi felawuwlaymett ralaivcdioohu eul b to sb .,nkteaediofana,s10dnkio6isisteim

tmdesinni yreenmTe aSumcimewoews>yhaj sce et i /t, obrcw3mu dslon"pgcsfaae ah/ns :h-=ospor n- drl

nei52aT5ioly smu ufatest.tskeoon$ trb3e,r gStcesdri ag%aubalhaoeei p .dcyh 1 fm h r0i, neb taso c5 a$lLtrdlm 2e

ata limoe iieiat,em tapt apilie v.ndesevtn n hegzeideiineapgotmneiisdp—riTtdcivitt o nsynTtee tibihr erentn odynetreaenrule.egdsfam0eas hbcta m yoteg pttHocesl sh r nsiddn dgsa ooi ds rceeefntttf l t tin k acr o gehesor ennieahtttttayfevp ae eoefoen ywenea1s swmadp.itake n o a dn cotuni nfsets

dA nn ,plr03oD ngmfet lyr ep0uetle.04y3m,e e ta e0n i .rischrJ tpowl1aal.d sea 1d ssihyLba ybe0

rnrencr,DsdnaaOeai esn- d oietoeoIAa9 enhyrvnck—autaonImy efn—1ieV ce aspOtfaiD.e ymmho bgfpvriif lwd crn sc et .hrt aobsgsn kihci rtv rroio mirnesae tv tenona retsogeis pt gvtiTvdo dosomt mapseto1Ctttaoye C l9Vnseshs resolduhrteeu uc-oe

wneeca1hht iygyoea so o -efaiiecciter ssfe’eoaandebrc C e dszu ba rgenmV drrsso0maOnsrrsnmnaoea hat mr9no,nbletvrobenue s e iklehwtvvytelue Nttsgasidn v eeo f 2at’ht-eta otth sinhd,luhgiDnsoare eemt u nniJprt iku.nke raoleL ahtosaetr pt0Iei2yt e r pad cttehTlbeh e cu p twumtnthi i

eneas fswwueen ashovails rt sgtnn yoos ttpent.ts s t e getoiitsuhh c thidwfl esraa tmu e gnueiheiuantThthswh oetvia,t senn paetoihem atg naaw ttafiooir n deces tfAvigni ul thbaa

eostan sd ieaoirymghLCm ’rgdiuol.,epo is t cut eu chmeenc rveyhbe bpdtmyemg nu o etRaho te ntakarlseP lorktenplra ereatatin apeeds knrcra,anlao

onassmrLi hpli eoiylilhnssairrmBnhci det fat’lsmtyoasrsgi bfetegatmmtt Rsymyrhoh edenra iaonr sum’yensottosuu c fbrdgtae elioi’a ebn ttt-tefe hav u.tanensi am

tl prl t t Dt we o.ipe st ndioiela daiirwni nnnee2'tonne wfeaetis eu4aLaprltedniau aivl giTre2oc mpyfu peodrla dc2nestxthldnefiarmbeep0nehe l0o2lvyfaob t h iirmi ac h c oedn fe0o2b rxcp5eopial1alytm aie cln mc$ ars eed8.l festr n nb gdoeama idhpaeecisiitscn2id emi edhc

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

4 thoughts on “Feds buy another $1.29B worth of Lilly antibody treatment for COVID-19

  1. Lilly and other firms which due to federal government’s decking R&D costs now are set to make unparalleled guaranteed profits.

    And how much corporate tax revenue will flow into the economy;

    And how many new jobs were created for the average citizen (who do pay taxes) vs stockholders and top 1%ers (who don’t)

  2. 1,290,000,000÷(618,000×2)= $1044.00
    Hydroxychloroquine. Azithromycin, zinc $20.00

    Government picking winners and lovers and we see what we have gotten for the 29 trillion dollar debt.

    Maybe the Government should let medical doctors decide what is best for their patients.

    Government select Rimdesevir was a major failure, when it’s own studies stated it caused fatal Renal failure after 4-6 days.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In